Experimental therapy of mental diseases with Edan, with special reference to rheumatic background.
D000275:Adjustment Disorders / Q000188:drug therapy; D000284:Administration, Oral; D001714:Bipolar Disorder / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy; D004048:Diethylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D010259:Paranoid Disorders / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy
D004048:Diethylamines; D012459:Salicylates